EpiCast Report: Trigeminal Neuralgia - Epidemiology Forecast to 2022

LONDON, Feb. 19, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

EpiCast Report: Trigeminal Neuralgia - Epidemiology Forecast to 2022

EpiCast Report: Trigeminal Neuralgia - Epidemiology Forecast to 2022

Summary

Trigeminal neuralgia, also called tic douloureux, is a chronic nerve disorder characterized by severe facial nerve. The condition is more common in women compared with men and most commonly affects people ages 50 years and older. Globally the diagnosed incidence of trigeminal neuralgia varies between 4.3 cases per 100,000 person-years in Rochester, Minnesota, US, and approximately 28.9 cases per 100,000 person-years in the Netherlands. The total lifetime prevalence of trigeminal neuralgia in people ages 18–65 years ranged from 0.1% in Norway to 0.3% in Germany. Though the condition is not life-threatening, the pain associated can be debilitating, causing significant loss of quality of life and a decrease in activity levels.

GlobalData epidemiologists forecast that the diagnosed incident cases of trigeminal neuralgia in the 7MM will grow at 16.70% over the next decade, from 98,804 cases in 2012 to 115,275 cases in 2022. Comparably, GlobalData's epidemiological analysis forecasts that the total prevalent cases of trigeminal neuralgia in the 7MM will grow at 15.0% over the next decade, from the estimated 842,086 cases in 2012 to 968,360 cases in 2022.

This increase in the number of incident and prevalent cases of trigeminal neuralgia in the 7MM can be attributed to changing population demographics in the respective markets rather than an actual forecast increase in the incidence and prevalence of trigeminal neuralgia.

Scope

- The trigeminal neuralgia EpiCast Report provides an overview of the risk factors and the global and historical trends for trigeminal neuralgia in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK and Japan). In addition, the report includes a 10-year epidemiological forecast (2012–2022) of diagnosed incident cases and total prevalent cases of trigeminal neuralgia segmented by age (ages 50–85+ years) and sex in these markets.
- The trigeminal neuralgia epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global trigeminal neuralgia market.
- Quantify patient populations in the global trigeminal neuralgia market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for trigeminal neuralgia therapeutics in each of the markets covered.

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 9
3.2.1 Elderly women are at increased risk for trigeminal neuralgia 9
3.3 Global Trends 10
3.4 Forecast Methodology 12
3.4.1 Sources Used 13
3.4.2 Forecast Assumptions and Methods, Incident Cases 15
3.4.3 Forecast Assumptions and Methods, Prevalent Cases 17
3.4.4 Sources Not Used 17
3.5 Epidemiology Forecast for Trigeminal Neuralgia (2012-2022), Incident Cases 18
3.5.1 Incident Cases of Trigeminal Neuralgia 18
3.5.2 Age-Specific Incident Cases of Trigeminal Neuralgia 20
3.5.3 Sex-Specific Incident Cases of Trigeminal Neuralgia 22
3.5.4 Age-Standardized Incidence of Trigeminal Neuralgia 24
3.6 Epidemiology Forecast for Trigeminal Neuralgia (2012-2022), Prevalent Cases 25
3.6.1 Age-Specific Prevalent Cases of Trigeminal Neuralgia 27
3.6.2 Sex-Specific Prevalent Cases of Trigeminal Neuralgia 29
3.6.3 Age-Standardized Prevalence of Trigeminal Neuralgia 31
3.7 Discussion 32
3.7.1 Epidemiological Forecast Insight 32
3.7.2 Limitations of the Analysis 33
3.7.3 Strengths of the Analysis 34
4 Appendix 36
4.1 Bibliography 36
4.2 About the Authors 37
4.2.1 Epidemiologists 37
4.2.2 Reviewers 37
4.2.3 Global Director of Epidemiology and Health Policy 38
4.2.4 Global Head of Healthcare 39
4.3 About GlobalData 40
4.4 About EpiCast 40
4.5 Disclaimer 41

List of Tables

Table 1: Epidemiological Data for Trigeminal Neuralgia 11
Table 2: 7MM, Sources of Trigeminal Neuralgia Incidence Data 12
Table 3: 7MM, Sources of Trigeminal Neuralgia Prevalence Data 12
Table 4: 7MM, Incident Cases of Trigeminal Neuralgia, Ages ?50 Years, Men and Women, N, 2012-2022 19
Table 5: 7MM, Incident Cases of Trigeminal Neuralgia, by Age, Men and Women, N, (Row %), 2012 21
Table 6: 7MM, Incident Cases of Trigeminal Neuralgia, by Sex, Ages ?50 Years, N (Row %), 2012 23
Table 7: 7MM, Prevalent Cases of Trigeminal Neuralgia, Ages ?50 Years, Men and Women, N, 2012-2022 26
Table 8: 7MM, Prevalent Cases of Trigeminal Neuralgia, by Age, Men and Women, N, (Row %), 2012 28
Table 9: 7MM, Prevalent Cases of Trigeminal Neuralgia, by Sex, Ages ?50 Years, N (Row %), 2012 30

List of Figures

Figure 1: 7MM, Incident Cases of Trigeminal Neuralgia, Ages ?50 Years, Men and Women, N, 2012-2022 19
Figure 2: 7MM, Incident Cases of Trigeminal Neuralgia, by Age, Men and Women, N, 2012 22
Figure 3: 7MM, Incident Cases of Trigeminal Neuralgia, by Sex, Ages ?50 Years, N, 2012 24
Figure 4: 7MM, Age-Standardized Incidence of Trigeminal Neuralgia (per 100,000 Population), Ages ?50 Years, Men and Women, 2012 25
Figure 5: 7MM, Prevalent Cases of Trigeminal Neuralgia, Ages ?50 Years, Men and Women, N, 2012-2022 26
Figure 6: 7MM, Prevalent Cases of Trigeminal Neuralgia, by Age, Men and Women, N, 2012 29
Figure 7: 7MM, Prevalent Cases of Trigeminal Neuralgia, by Sex, Ages ?50 Years, N, 2012 31

Read the full report:
EpiCast Report: Trigeminal Neuralgia - Epidemiology Forecast to 2022
http://www.reportbuyer.com/pharma_healthcare/diseases/epicast_report_trigeminal_neuralgia_epidemiology_forecast_2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer